American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 281.e1-281.e5 , March 2008

Maternal C-reactive protein and developmental programming of atherosclerosis

  • Antonio Liguori, MD

      Affiliations

    • Regional Hospital of Pellegrini and Loreto Crispi Hospital, 2nd School of Medicine, Federico II University, Naples, Italy
    • ,
  • Francesco P. D’Armiento, MD

      Affiliations

    • Division of Human Pathology, 2nd School of Medicine, Federico II University, Naples, Italy
    • ,
  • Antonio Palagiano, MD

      Affiliations

    • Division of Obstetrics and Gynecology, Department of General Pathology and Excellence Research Center on Cardiovascular Diseases, 1st School of Medicine, II University of Naples, Naples, Italy
    • ,
  • Wulf Palinski, MD

      Affiliations

    • Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, CA.
    • ,
  • Claudio Napoli, MD, PhD

      Affiliations

    • Division of Clinical Pathology, Department of General Pathology and Excellence Research Center on Cardiovascular Diseases, 1st School of Medicine, II University of Naples, Naples, Italy
    • Corresponding Author InformationReprints: Prof Claudio Napoli, Department of General Pathology, Division of Clinical Pathology and Excellence Research Center on Cardiovascular Diseases, 1st School of Medicine, II University of Naples, Complesso S. Andrea delle Dame 80138 Naples, Italy.

Received 26 April 2007 ,Accepted 14 November 2007.

References 

  1. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet. 1989;2:577–580
  2. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;341:938–941
  3. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J. 2002;16:1348–1360
  4. Napoli C, Palinski W. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications. Eur Heart J. 2001;22:4–9
  5. Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia (Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions). J Clin Invest. 1997;100:2680–2690
  6. Napoli C, Witztum JL, Calara F, de Nigris F, Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res. 2000;87:946–952
  7. Palinski W, D’Armiento FP, Witztum JL, et al. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res. 2001;89:991–996
  8. Napoli C, Glass CK, Witztum JL, Deutsch R, D’Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354:1234–1241
  9. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83:456S–460S
  10. Yamashita T, Freigang S, Eberle C, et al. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res. 2006;99:E51–E64
  11. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study group. Lancet. 1997;349:462–466
  12. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  13. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565
  14. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003;107:391–397
  15. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(suppl):9S–16S
  16. Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation. 2001;103:1191–1193
  17. Engler MM, Engler MB, Malloy MJ, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) trial. Circulation. 2003;108:1059–1063
  18. Volanakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci. 1982;389:235–250
  19. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement–C-reactive protein complexes. J Immunol. 1996;157:473–479
  20. Li SH, Szmitko PE, Weisel RD, et al. C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation. 2004;109:833–836
  21. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  22. Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107:1783–1790
  23. Blaschke F, Bruemmer D, Yin F, et al. C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation. 2004;110:579–587
  24. Napoli C, Witztum JL, de Nigris F, Palumbo G, D’Armiento FP, Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation. 1999;99:2003–2010
  25. Palinski W, Napoli C. Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol. 2002;22:1745–1750
  26. Taylor PD, Khan IY, Hanson MA, Poston L. Impaired EDHF-mediated vasodilatation in adult offspring of rats exposed to a fat-rich diet in pregnancy. J Physiol. 2004;558:943–951
  27. Khan IY, Dekou V, Douglas G, et al. A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regul Integr Comp Physiol. 2005;288:R127–R133
  28. Bottiglioni F, Guerresi E, Tirelli R, Giordano G. On hypercholesteremia of pregnancy (Contribution to the study of the phenomenon and its current interpretive possibilities). Riv Ital Ginecol. 1967;51:20–50
  29. Napoli C, de Nigris F, Welch JS, et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation. 2002;105:1360–1367
  30. Heitzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 1996;93:1346–1353
  31. Yang Z, Knight CA, Mamerow MM, et al. Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/- mice fed a chow diet. Circulation. 2004;110:3715–3720
  32. Luo ZC, Fraser WD, Julien P, et al. Tracing the origins of “fetal origins” of adult diseases: programming by oxidative stress?. Med Hypotheses. 2006;66:38–44
  33. Napoli C, de Nigris F, Palinski W. Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem. 2001;82:674–682

 Cite this article as: Liguori A, D’Armiento FP, Palagiano A, Palinski W, Napoli C. Maternal C-reactive protein and developmental programming of atherosclerosis. Am J Obstet Gynecol 2008;198:281.e1-281.e5.

 This study was supported by grants from the Regione Campania and Ministery of University and Research P.R.I.N. 2006 (C. N.) and National Institutes of Health grants HL067792 and HL56989 (C. N. and W.P.).

PII: S0002-9378(07)02176-X

doi: 10.1016/j.ajog.2007.11.027

American Journal of Obstetrics & Gynecology
Volume 198, Issue 3 , Pages 281.e1-281.e5 , March 2008

Article Tools

* Image Usage & Resolution